Loading company…
Riskpilot
← Back to search
Sign in
Get full access
AINOVA MedTech Oy
OY
Active
Y-tunnus 3171210-7
C/O Terkko Haartmaninkatu 4
Muu luonnontieteellinen ja tekninen tutkimus ja kehitt. · NACE 72190
Est. 2020
— employees
www.ainovamedtech.com
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2021
EUR 11K
EBITDA margin
53.2%
Equity ratio
79.7%
Financial strength
Net profit 2021
EUR 5K
EBITDA — year on year
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2021
Key figures
Annual report 2021
Revenue
EUR 11K
—
EBITDA
EUR 6K
—
Net profit
EUR 5K
—
Total assets
EUR 6K
—
Equity
EUR 5K
—
Employees
—
—
Company information
Legal name
AINOVA MedTech Oy
Y-tunnus number
3171210-7
Legal form
Osakeyhtiö
NACE code
72190 · Muu luonnontieteellinen ja tekninen tutkimus ja kehitt.
Founded
16. marraskuuta 2020
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Selvitystilan aikana selvitysmiehet yhdessä
Company purpose
Yhtiön toimialana on Lääketieteellinen tutkimus ja kehittäminen (72191).
Contact
Address
C/O Terkko Haartmaninkatu 4
Phone
+358408436061
Email
info@ainovamedtech.com
Website
www.ainovamedtech.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Muu luonnontieteellinen ja tekninen tutkimus ja kehitt.
Companies in Helsinki
All Finland companies
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2021
Income statement
EUR thousands
Item
2021
Revenue
11
Staff expenses
—
EBITDA
6
Depreciation & amort.
—
EBIT
6
Net financials
—
Profit before tax
6
Tax
1
Net profit
5
Balance sheet
EUR thousands
Item
2021
Total assets
6
Equity
5
Long-term debt
—
Short-term debt
1
Total debt
1
Financial ratios
5-year trend
EBITDA margin
53.2%
This company
15.8%
Market median
+237% vs market
2021
2021
Equity ratio
79.7%
This company
38.2%
Market median
+109% vs market
2021
2021
Return on equity
100.0%
This company
18.4%
Market median
+443% vs market
2021
2021
Net profit margin
42.6%
This company
8.1%
Market median
+426% vs market
2021
2021
Asset turnover
1.87×
This company
1.12×
Market median
+67% vs market
2021
2021
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
2021
2021
Annual reports & filings
Annual report 2021
Filed via PRH / YTJ · Period 2020-11-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
JW
Jack William Scott Parker
Liquidator
Liquidator
2022
OO
Onni Oscar Eriksson
Liquidator
Liquidator
2022
Former (2)
LJ
Lara Jasim
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2021 – 2022
DW
Dan Wilhelm Colliander
Deputy Member
Deputy Member
2020 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Former (1)
AS
Amanda Stella Kristiina Ehrnrooth
Board of Directors
2020 – 2021
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of AINOVA MedTech Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Lara Jasim
Deputy Chief Executive Officer
0 companies
Dan Wilhelm Colliander
Deputy Member
0 companies
Jack William Scott Parker
Liquidator
0 companies
Onni Oscar Eriksson
Liquidator
0 companies
Amanda Stella Kristiina Ehrnrooth
Board of Directors
0 companies